EnlitenAI is an AI driven platform for neurological conditions aimed at better management and treatment of Epilepsy.
EnlitenAI has raised $455K in total funding. The most recent round was Pre-Seed. The last funding was announced in May 2023.
EnlitenAI's investors include Aurelia Ventures.
EnlitenAI is headquartered in Tracy, United States.
EnlitenAI is an AI driven platform for neurological conditions aimed at better management and treatment of Epilepsy.
EnlitenAI is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EnlitenAI — Funding & Investors." VCBacked, May 1, 2023, https://www.vcbacked.co/company/enlitenai. Accessed September 30, 2026.
VCBacked. (2023). EnlitenAI — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/enlitenai
{{cite web |title=EnlitenAI — Funding & Investors |url=https://www.vcbacked.co/company/enlitenai |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated